SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BrainStorm Cell Therapeutics Inc. Enters Into Agreement with FDA Specialist, PharmaNet, Inc., for the Development of ALS Human Clinical Trial Protocol in the USA